Linzess Constella — Net revenues
Products & Services · Net revenuesAbbVie Linzess Constella — Net revenues decreased by 46.3% to $175.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 24.9%, from $233.00M to $175.00M. Over 4 years (FY 2021 to FY 2025), Linzess Constella — Net revenues shows a downward trend with a -3.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates strong market adoption and effective commercial execution for this therapeutic, while a decrease may signal increased competition, patent expiration, or shifts in prescribing patterns.
Detailed definition
This metric represents the total net sales generated by the Linzess/Constella product line, a key gastrointestinal thera...
Peer comparison
Comparable to product-level revenue reporting for specific blockbuster drugs or therapeutic franchises within other large-cap pharmaceutical companies.
abbv_segment_linzess_constella_net_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $268.00M | $261.00M | $287.00M | $240.00M | $255.00M | $271.00M | $269.00M | $259.00M | $278.00M | $288.00M | $283.00M | $266.00M | $221.00M | $234.00M | $233.00M | $148.00M | $258.00M | $326.00M | $175.00M |
| QoQ Change | — | -2.6% | +10.0% | -16.4% | +6.3% | +6.3% | -0.7% | -3.7% | +7.3% | +3.6% | -1.7% | -6.0% | -16.9% | +5.9% | -0.4% | -36.5% | +74.3% | +26.4% | -46.3% |
| YoY Change | — | — | — | — | -4.9% | +3.8% | -6.3% | +7.9% | +9.0% | +6.3% | +5.2% | +2.7% | -20.5% | -18.8% | -17.7% | -44.4% | +16.7% | +39.3% | -24.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is AbbVie's linzess constella — net revenues?
- AbbVie (ABBV) reported linzess constella — net revenues of $175.00M in Q4 2025.
- How has AbbVie's linzess constella — net revenues changed year-over-year?
- AbbVie's linzess constella — net revenues decreased by 24.9% year-over-year, from $233.00M to $175.00M.
- What is the long-term trend for AbbVie's linzess constella — net revenues?
- Over 4 years (2021 to 2025), AbbVie's linzess constella — net revenues has grown at a -3.3% compound annual growth rate (CAGR), from $1.04B to $907.00M.
- What does linzess constella — net revenues mean?
- The total net revenue generated from the sale of the Linzess/Constella pharmaceutical product line.